|
|
CENTER FOR DRUG EVALUATION AND RESEARCH
DIVISION of
DRUG INFORMATION
Your source for the latest drug information. Know the moment it happens.
|
|
|
FDA Releases Version 4.1 of OND Custom Medical Queries
The U.S. Food and Drug Administration’s (FDA) Office of New Drugs (OND) has released version 4.1 of the OND Custom Medical Queries (OCMQs), which includes terms released in MedDRA v27.0 and earlier. OCMQ version 4.1 includes several minor updates to adverse event terms based on user feedback and committee review. OCMQs are intended to capture clinically meaningful groupings (i.e., safety signals) in premarketing safety data. OCMQs have become an important component of premarket drug safety evaluations, as they promote a consistent safety signal detection strategy across OND Divisions.
|
|
This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO- FDA (1-888-463-6332) or 301-796-3400 from 8:00 am - 4:30 pm ET Monday - Friday. You can also email us at: druginfo@fda.hhs.gov. |
|
|
|
